Crossref
Inflammatory Risk and P2Y12 Inhibition After Acute Coronary Syndromes
Thrombosis and Haemostasis · 10.11.2026
DOI: 10.1055/a-2999-4165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 10.11.2026. Verfasst von Luigi Cutore und 1 weiteren Autor:innen. Beteiligte Einrichtung: A.O.U. Policlinico "G. Rodolico - San Marco" - University of Catania, Cardiology, Italy/Catania, Italy, Catania.
Abstract (Originalsprache)
No Abstract
Autor:innen und Institutionen
- A.O.U. Policlinico "G. Rodolico - San Marco" - University of Catania, Cardiology, Italy/Catania, Italy, Catania.
- University of Catania, Cardiology Unit, Italy, Italy, Catania.
ORCID-Profile: Davide Capodanno
Zitieren
APA
Cutore, L., & Capodanno, D. (2026). Inflammatory Risk and P2Y12 Inhibition After Acute Coronary Syndromes. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2999-4165
Vancouver
Cutore L, Capodanno D. Inflammatory Risk and P2Y12 Inhibition After Acute Coronary Syndromes. Thrombosis and Haemostasis. 2026. doi:10.1055/a-2999-4165
BibTeX
@article{Cutore2026,
author = {Cutore, Luigi and Capodanno, Davide},
title = {Inflammatory Risk and P2Y12 Inhibition After Acute Coronary Syndromes},
journal = {Thrombosis and Haemostasis},
year = {2026},
doi = {10.1055/a-2999-4165}
}
EUVIMED